Fintel reports that on November 4, 2025, Berenberg Bank reiterated coverage of BP p.l.c. - Depositary Receipt (NYSE:BP) with a Buy recommendation. Analyst Price Forecast Suggests 2.70% Upside As of ...

​SAP SE (NYSE:SAP) is one of the Profitable SaaS Companies for 2026. On February 10, Nay Soe Naing from Berenberg Bank reiterated a Buy rating on the stock with a €250 price target. The bullish ...

Sanofi (NASDAQ:SNY) is one of the Most Undervalued Foreign Stocks to Buy According to Analysts. On January 20, Berenberg Bank reiterated a Buy rating on the stock with a $62 price target. Earlier on ...

Detailed price information for Renault Sa Unsp/Adr (RNLSY) from The Globe and Mail including charting and trades.

Fintel reports that on November 27, 2025, Berenberg Bank reiterated coverage of Entain Plc - Depositary Receipt (OTCPK:GMVHY) with a Buy recommendation. As of November 17, 2025, the average one-year ...

In a report released yesterday, Victoria Lambert from Berenberg Bank maintained a Buy rating on Gerresheimer (0NTI – Research Report), with a price target of €110.00. The company’s shares closed ...

Analysts at Berenberg initiated coverage on The Magnum Ice Cream Company with a 'hold' rating and a 1,270p price target on ...

Analysts at Berenberg lowered their targret price on software firm Cerillion from 2,125p to 2,000p on Wednesday as it said the group was now "accelerating into the AI era".

In addition to Berenberg Bank, Exail Technologies also received a Buy from Kepler Capital ‘s Thomas Renaud in a report issued on February 18. However, on February 4, TipRanks – Google reiterated a ...

In a report released yesterday, Nick Anderson CFA from Berenberg Bank maintained a Buy rating on LVMH Moet Hennessy Louis Vuitton (0HAU – Research Report), with a price target of €740.00. The ...

As of November 17, 2025, the average one-year price target for Entain is $15.98/share. The forecasts range from a low of $12.48 to a high of $20.52. The average price target represents an increase of ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025. On January 7, Berenberg Bank reiterated a Buy rating on AstraZeneca PLC (NASDAQ:AZN) with a price target of $95. The ...